The recent article by Biancuzzo et al (1) presents data showing that vitamin D is equally bioavailable from orange juice and gel caps. This equivalence of vehicle was shown for both vitamin D 2 and vitamin D 3 . The article is important because it has implications for health policy.
However, health professionals, scientists, and the public alike are interpreting this article as evidence that vitamin D 2 is equivalent to vitamin D 3 , which is an issue that was not addressed by Biancuzzo et al (1) . The results present no direct comparison of the area under the curve (AUC) for serum 25-hydroxyvitamin D for vitamin D 2 compared with vitamin D 3 .
We are writing to emphasize that the conclusion of the article by Biancuzzo et al (1) is unfortunately ambiguous and hence subject to misinterpretation; the authors failed to make it clear that their study was not designed to compare vitamin D 2 with vitamin D 3 . Without such clarification, the true interpretation of the findings of Biancuzzi et al will be lost to most who read their article.
The authors had no conflicts of interest to declare. 
Susan Lanham-New

Reply to S Lanham-New et al
Dear Sir:
We were pleased that Lanham-New et al appreciated that this article has important implications for health policy. It is, however, surprising and disappointing that these 3 experts did not fully understand the design, outcomes, and conclusions of our study. This study was designed to compare not only the bioavailability of vitamin D 2 and vitamin D 3 in orange juice with that in capsules, but it also was designed to confirm the previous report (1) There was no significant difference between these 2 groups in mean total 25(OH)D AUC (P ¼ 0.196, independent-samples t test).
We also evaluated the difference in mean total 25(OH)D AUC between the original 5 randomization groups. The analysis results show a significant overall group difference in mean total 25(OH)D AUC (P ¼ 0.0406, ANOVA F test), but post hoc testing indicated that the only significant pairwise comparison was between the placebo (PL) and OJ(D 3 )1PL groups; there were no significant differences in the mean total 25(OH)D AUC between the 4 groups treated with either vitamin D 3 or vitamin D 2 ( Table 1) . Therefore, on the basis of all of these analyses, it can be concluded with a high degree of certainty that vitamin D 2 is equally as effective as vitamin D 3 in raising and maintaining serum total 25(OH)D concentrations and that vitamin D 2 is equally as bioavailable as vitamin D 3 .
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